Literature DB >> 19882397

Screening for potential prescription opioid misuse in a michigan medicaid population.

Laurie S Braker1, Anna E Reese, Randall O Card, Robert S Van Howe.   

Abstract

BACKGROUND AND OBJECTIVES: The study's objective was to identify patients at risk for ineffective pain management using patient-specific opioid prescription data.
METHODS: We conducted a retrospective review of payer opioid prescription data and patient charts from a rural family medicine group with a residency program. Sixty-one patients were identified who had received three or more prescriptions from two or more providers over a 6-month period. We noted the number of prescriptions and providers, type of medication prescribed, evidence of a medication management agreement (MMA), early refills, increasing doses, frequent telephone calls, reports of lost or stolen medication, history of drug abuse, and proper chart documentation.
RESULTS: Seventy percent of the patients were female, 35% had a history of drug abuse, 15% had MMAs, and only 55% had accurate office chart documentation. The number of prescriptions in a 6-month period averaged 8.4 (SD=5.5, range 3 to 28). The average number of prescribers was 3.7 (SD=1.8, range 2 to 10). Patients using non-opioid analgesics had 3.2 fewer prescriptions per 6 months and were less likely to have six or more prescriptions (OR=0.24, 95% CI=0.08--0.73) than those on opioids alone. Concurrent use of non-opioid analgesics, escalating opioid dosage, and number of providers best predicted the number of opioid prescriptions.
CONCLUSIONS: Payer data was useful in identifying patients who receive larger-than-expected numbers of opioid prescriptions and factors associated with those larger prescription numbers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19882397

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  11 in total

1.  Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse.

Authors:  Alicia Grattan; Mark D Sullivan; Kathleen W Saunders; Cynthia I Campbell; Michael R Von Korff
Journal:  Ann Fam Med       Date:  2012 Jul-Aug       Impact factor: 5.166

2.  Developing a framework of care for opioid medication misuse in community pharmacy.

Authors:  Gerald Cochran; Adam J Gordon; Craig Field; Jennifer Bacci; Ranjita Dhital; Thomas Ylioja; Maxine Stitzer; Thomas Kelly; Ralph Tarter
Journal:  Res Social Adm Pharm       Date:  2015-05-08

3.  Prescription opioid use: Patient characteristics and misuse in community pharmacy.

Authors:  Gerald Cochran; Jennifer L Bacci; Thomas Ylioja; Valerie Hruschak; Sharon Miller; Amy L Seybert; Ralph Tarter
Journal:  J Am Pharm Assoc (2003)       Date:  2016-03-24

Review 4.  Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).

Authors:  Bianca Blanch; Nicholas A Buckley; Leigh Mellish; Andrew H Dawson; Paul S Haber; Sallie-Anne Pearson
Journal:  Drug Saf       Date:  2015-06       Impact factor: 5.606

5.  Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research.

Authors:  Gerald T Cochran; Rafael J Engel; Valerie J Hruschak; Ralph E Tarter
Journal:  J Pharm Pract       Date:  2016-07-08

6.  Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.

Authors:  Gerald Cochran; Valerie Hruschak; Jennifer L Bacci; Kenneth C Hohmeier; Ralph Tarter
Journal:  Res Social Adm Pharm       Date:  2016-11-15

Review 7.  Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review.

Authors:  Gerald Cochran; Bongki Woo; Wei-Hsuan Lo-Ciganic; Adam J Gordon; Julie M Donohue; Walid F Gellad
Journal:  Subst Abus       Date:  2015-02-11       Impact factor: 3.716

Review 8.  Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.

Authors:  Roxanne Meyer; Anisha M Patel; Stacy K Rattana; Tiffany P Quock; Samir H Mody
Journal:  Popul Health Manag       Date:  2014-12       Impact factor: 2.459

9.  The POPPY Research Programme protocol: investigating opioid utilisation, costs and patterns of extramedical use in Australia.

Authors:  Louisa Degenhardt; Bianca Blanch; Natasa Gisev; Briony Larance; Sallie Pearson
Journal:  BMJ Open       Date:  2015-01-28       Impact factor: 2.692

Review 10.  Prescription opioid abuse: pharmacists' perspective and response.

Authors:  Gerald Cochran; Valerie Hruschak; Brooke DeFosse; Kenneth C Hohmeier
Journal:  Integr Pharm Res Pract       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.